logo
Book a meeting
Carthera

Carthera

Medical Devices, Lyon, Colorado, United States, 1-10 Employees

carthera.eu

  • twitter
  • LinkedIn

Who is CARTHERA

Carthera is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat a wide range of severe brain disorders. Carthera has developed a pr...

Read More

lock icon Get Full Access
map
  • Lyon, Colorado, United States Headquarters: Lyon, Colorado, United States
  • 2010 Date Founded: 2010
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Medical Devices

SIC SIC Code: 8731 | NAICS Code: 541715 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from CARTHERA

Carthera Org Chart and Mapping

Employees
Michael Canney

Michael Canney

Chief Scientific Officer

See Full Org Chart arrow
email-formate-icon
View Email Formats for Carthera
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding Carthera

Answer: Carthera's headquarters are located at Lyon, Colorado, United States

Answer: Carthera's official website is https://carthera.eu

Answer: Carthera's revenue is $1 Million to $5 Million

Answer: Carthera's SIC: 8731

Answer: Carthera's NAICS: 541715

Answer: Carthera has 1-10 employees

Answer: Carthera is in Medical Devices

Answer: Carthera contact info: Phone number: Website: https://carthera.eu

Answer: Carthera is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat a wide range of severe brain disorders. Carthera has developed a proprietary device called SonoCloud- a groundbreaking medical device that emits ultrasound to temporarily increase the permeability of the blood vessels in the brain. By using SonoCloud, the therapeutic efficacy of new and existing therapies can be unlocked and harnessed to improve the treatment of a wide range of brain diseases: oncology indications (glioblastoma, brain metastasis) or neurodegenerative diseases (such as Alzheimers Disease, ALS). The products developed by Carthera are in clinical or preclinical evaluation (not FDA or CE approved) and are not available for sale.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access